Literature DB >> 9054969

Mutations at nucleotides G2251 and U2585 of 23 S rRNA perturb the peptidyl transferase center of the ribosome.

R Green1, R R Samaha, H F Noller.   

Abstract

Previous experiments have shown that the phylogenetically conserved G2252 of 23 S rRNA forms a Watson-Crick base-pair with C74 of peptidyl-tRNA. In the studies presented here, site-directed mutations were introduced at two other conserved positions in 23 S rRNA, G2251 and U2585, that were previously implicated in interaction of the CCA acceptor end of tRNA with the 50 S subunit P site. The mutant 23 S rRNAs were characterized by determining (1) the in vivo phenotypes, (2) the ability of mutant ribosomes to bind tRNA oligonucleotide fragments in vitro, using footprinting with allele-specific primer extension and (3) the ability of mutant ribosomes to catalyze peptide bond formation using a chimeric reconstitution approach. Mutations at either position confer a dominant lethal phenotype when the mutant 23 S rRNA is coexpressed with the endogenous wild-type 23 S rRNA. Mutations at 2585 disrupt binding of the wild-type (CCA) tRNA oligonucleotide fragment and cause a modest decrease in the peptidyl transferase activity of reconstituted ribosomes. By contrast, mutations at 2251 abolish both binding of the wild-type (CCA) tRNA fragment and peptidyl transferase activity using the wild-type tRNA fragment. In neither case was the loss of binding or peptidyl transferase activity suppressed by mutations in the tRNA oligonucleotide fragment. Chemical modification analysis revealed that mutations at 2251 perturb the reactivity of bases 2584 to 2586, providing further evidence that the 2250 loop of 23 S rRNA interacts, either directly or indirectly, with the 2585 region in the central loop of domain V of 23 S rRNA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9054969     DOI: 10.1006/jmbi.1996.0780

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  24 in total

1.  Peptidyl transferase antibiotics perturb the relative positioning of the 3'-terminal adenosine of P/P'-site-bound tRNA and 23S rRNA in the ribosome.

Authors:  S V Kirillov; B T Porse; R A Garrett
Journal:  RNA       Date:  1999-08       Impact factor: 4.942

2.  An in vitro evolved precursor tRNA with aminoacylation activity.

Authors:  H Saito; D Kourouklis; H Suga
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

3.  A minihelix-loop RNA acts as a trans-aminoacylation catalyst.

Authors:  N Lee; H Suga
Journal:  RNA       Date:  2001-07       Impact factor: 4.942

4.  Interference probing of rRNA with snoRNPs: a novel approach for functional mapping of RNA in vivo.

Authors:  Ben Liu; Maurille J Fournier
Journal:  RNA       Date:  2004-07       Impact factor: 4.942

5.  The hybrid state of tRNA binding is an authentic translation elongation intermediate.

Authors:  Silke Dorner; Julie L Brunelle; Divya Sharma; Rachel Green
Journal:  Nat Struct Mol Biol       Date:  2006-02-26       Impact factor: 15.369

6.  Toward ribosomal RNA catalytic activity in the absence of protein.

Authors:  Rachel M Anderson; Miyun Kwon; Scott A Strobel
Journal:  J Mol Evol       Date:  2007-04-05       Impact factor: 2.395

7.  Active destruction of defective ribosomes by a ubiquitin ligase involved in DNA repair.

Authors:  Alan G Hinnebusch
Journal:  Genes Dev       Date:  2009-04-15       Impact factor: 11.361

8.  Specific telomerase RNA residues distant from the template are essential for telomerase function.

Authors:  J Roy; T B Fulton; E H Blackburn
Journal:  Genes Dev       Date:  1998-10-15       Impact factor: 11.361

9.  23S rRNA positions essential for tRNA binding in ribosomal functional sites.

Authors:  M Bocchetta; L Xiong; A S Mankin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

10.  R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.

Authors:  Eugene Skripkin; Timothy S McConnell; Joseph DeVito; Laura Lawrence; Joseph A Ippolito; Erin M Duffy; Joyce Sutcliffe; François Franceschi
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.